Search details
1.
Indigenous Australian genomes show deep structure and rich novel variation.
Nature
; 624(7992): 593-601, 2023 Dec.
Article
in English
| MEDLINE | ID: mdl-38093005
2.
The landscape of genomic structural variation in Indigenous Australians.
Nature
; 624(7992): 602-610, 2023 Dec.
Article
in English
| MEDLINE | ID: mdl-38093003
3.
Equitable Expanded Carrier Screening Needs Indigenous Clinical and Population Genomic Data.
Am J Hum Genet
; 107(2): 175-182, 2020 08 06.
Article
in English
| MEDLINE | ID: mdl-32763188
4.
The efficacy of combination treatment with elotuzumab and lenalidomide is dependent on crosstalk between natural killer cells, monocytes and myeloma cells.
Haematologica
; 108(1): 83-97, 2023 01 01.
Article
in English
| MEDLINE | ID: mdl-35770527
5.
CAR T-Cell Therapy for Glioblastoma.
N Engl J Med
; 390(14): 1329-1332, 2024 Apr 11.
Article
in English
| MEDLINE | ID: mdl-38598802
6.
Cellular and Molecular Mechanisms of CD8+ T Cell Differentiation, Dysfunction and Exhaustion.
Int J Mol Sci
; 21(19)2020 Oct 05.
Article
in English
| MEDLINE | ID: mdl-33027962
7.
Finding the Keys to the CAR: Identifying Novel Target Antigens for T Cell Redirection Immunotherapies.
Int J Mol Sci
; 21(2)2020 Jan 14.
Article
in English
| MEDLINE | ID: mdl-31947597
8.
The Evolving Protein Engineering in the Design of Chimeric Antigen Receptor T Cells.
Int J Mol Sci
; 21(1)2019 Dec 27.
Article
in English
| MEDLINE | ID: mdl-31892219
9.
The strength of T cell receptor signal controls the polarization of cytotoxic machinery to the immunological synapse.
Immunity
; 31(4): 621-31, 2009 Oct 16.
Article
in English
| MEDLINE | ID: mdl-19833087
10.
Perforin forms transient pores on the target cell plasma membrane to facilitate rapid access of granzymes during killer cell attack.
Blood
; 121(14): 2659-68, 2013 Apr 04.
Article
in English
| MEDLINE | ID: mdl-23377437
11.
Rapid and unidirectional perforin pore delivery at the cytotoxic immune synapse.
J Immunol
; 191(5): 2328-34, 2013 Sep 01.
Article
in English
| MEDLINE | ID: mdl-23885110
12.
Synthetic biology, genetic circuits and machine learning: a new age of cancer therapy.
Mol Oncol
; 17(6): 946-949, 2023 Jun.
Article
in English
| MEDLINE | ID: mdl-37002698
13.
From signalling pathways to targeted therapies: unravelling glioblastoma's secrets and harnessing two decades of progress.
Signal Transduct Target Ther
; 8(1): 400, 2023 10 20.
Article
in English
| MEDLINE | ID: mdl-37857607
14.
Flow Cytometry Identification of Cell Compartments in the Murine Brain.
Methods Mol Biol
; 2691: 185-198, 2023.
Article
in English
| MEDLINE | ID: mdl-37355546
15.
Human EGFRvIII chimeric antigen receptor T cells demonstrate favorable safety profile and curative responses in orthotopic glioblastoma.
Clin Transl Immunology
; 12(3): e1440, 2023.
Article
in English
| MEDLINE | ID: mdl-36890859
16.
HER2 chimeric antigen receptor T cell immunotherapy is an effective treatment for diffuse intrinsic pontine glioma.
Neurooncol Adv
; 5(1): vdad024, 2023.
Article
in English
| MEDLINE | ID: mdl-37152812
17.
A combined immunopeptidomics, proteomics, and cell surface proteomics approach to identify immunotherapy targets for diffuse intrinsic pontine glioma.
Front Oncol
; 13: 1192448, 2023.
Article
in English
| MEDLINE | ID: mdl-37637064
18.
Endogenous H3.3K27M derived peptide restricted to HLA-A∗02:01 is insufficient for immune-targeting in diffuse midline glioma.
Mol Ther Oncolytics
; 30: 167-180, 2023 Sep 21.
Article
in English
| MEDLINE | ID: mdl-37674626
19.
To go or not to go? Biological logic gating engineered T cells.
J Immunother Cancer
; 10(4)2022 04.
Article
in English
| MEDLINE | ID: mdl-35379738
20.
De novo-designed transmembrane domains tune engineered receptor functions.
Elife
; 112022 05 04.
Article
in English
| MEDLINE | ID: mdl-35506657